• Posted: November 8, 2018 U.S. Food and Drug Administration Approves Empliciti® (elotuzumab) Plus...

    READ MORE
  • Posted: November 6, 2018 A Note From Our Patient/Caregiver Bloggers Allan & Deb Osborne

    READ MORE
  • Posted: November 1, 2018 Verily Advisory Board Series: Kathy Giusti on driving change for better health

    READ MORE
  • Posted: October 31, 2018 Breakthrough in Immunotherapy and Myeloma Prevention

    READ MORE
  • Posted: October 4, 2018 Precision medicine needs a business mindset in order to flourish

    READ MORE
  • Posted: September 28, 2018 FDA Grants De Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay...

    READ MORE
  • Posted: September 28, 2018 2018 MRD Meeting in NYC

    READ MORE
  • Posted: September 28, 2018 New Compass Findings

    READ MORE
  • Posted: September 11, 2018 San Diego Myeloma 2018 Day 2

    READ MORE
  • Posted: September 10, 2018 San Diego Myeloma 2018 Day 1

    READ MORE

Page 1/17